Researchers have developed a rapid, multiplexed genotyping method to identify the single nucleotide polymorphisms (SNPs) that affect warfarin dose.

The family dog may not only be a friendly companion but also a reflection of community health.

Dozens of National Jewish Health faculty presented their latest research findings at the annual meeting of the American Academy of Allergy Asthma & Immunology in New Orleans Feb 27-March 2, 2010. Below are several noteworthy presentations. Vitamin D May Boost Effectiveness of Corticosteroids in Asthma Vitamin D enhances the activity of the corticosteroid dexamethasone more than ten-fold in cells taken from asthma patients…

The Society of Interventional Radiology (SIR) will present the latest research on treatments for individuals with liver, breast, soft tissue, colon, prostate, lung and pancreatic cancers; painful spinal fractures; peripheral arterial disease (PAD); uterine fibroids; and more at its 35th Annual Scientific Meeting March 13 -18 at the Tampa Convention Center. More than 5,000 physicians, scientists and allied health professionals are expected to attend this premier IR event…

People may avoid milk and other dairy products due to concerns about lactose intolerance, but eliminating these nutrient-rich foods may not only be unnecessary to manage the condition - it could impact diet and health, concludes a panel of experts assembled by the National Institutes of Health (NIH). The NIH Consensus Development Conference on Lactose Intolerance and Health was convened to examine the latest research on lactose intolerance, strategies to manage the condition and the health outcomes of diets that exclude dairy foods…

Researchers are investigating new ways for developing a novel painkiller based on natural compounds found in the venom of scorpions. These compounds have gone through millions of years of evolution and some show high efficacy and specificity for certain components of the body with no side effects.

A few minor variations in one gene may make a difference in athletic endurance, according to a new study.

Researchers have discovered a new mechanism within human cells that constantly protects us against disease.

New research suggests that the ability of right side of the heart to pump blood may be an indication of the risk of death to heart-failure patients whose condition is caused by low function by the left side of their heart.

Scientists are reporting the first-ever data to show that the enzyme calcineurin is critical in controlling normal development and function of heart cells, and that loss of the protein leads to heart problems and death in genetically modified mice. The study demonstrates that calcineurin in hearts of mice is directly linked to proper cardiac muscle contraction, rhythm and maintenance of heart activity.